Monmouth Medical Center and LifebankUSA Launches Program for Placental and Cord Blood Stem Cell Banking
News Dec 27, 2007
Monmouth Medical Center, an affiliate of the Saint Barnabas Health Care System has announced that its Department of Obstetrics and Gynecology has established a partnership with LifebankUSA, a New Jersey-based cord blood banking service, to establish the Monmouth Medical Center-LifebankUSA Placenta-Cord Banking Program.
The new program, south Jersey’s first hospital affiliated program for banking both placenta-derived and cord blood stem cells, will educate expectant parents regarding stem cell banking services when giving birth at the Medical Center.
“We are pleased to have partnered with LifebankUSA to offer this service for our families who are considering storing their newborn’s stem cells,” Robert A. Graebe, MD, Chairman of the Department of Obstetrics and Gynecology at Monmouth Medical Center, which handles more than 4,200 deliveries a year. “This initiative is part of our ongoing effort to foster long-term health and provide families with the best and latest in healthcare services.”
“Our new program with Monmouth Medical Center will provide families the ability to preserve the most stem cells possible,” said Robert Hariri, M.D., Ph.D., CEO of LifebankUSA. “Parents can significantly increase the number of stem cells collected when they choose to bank both cord blood and placental stem cells. As a locally-based company, LifebankUSA is especially pleased to have established a formal relationship with an acclaimed New Jersey medical center.”
LifebankUSA, based in Cedar Knolls, N.J., and a division of Summit-based Celgene Corporation, is an AABB-accredited, ISO-certified stem cell banking service. Its stem cell processing and storage facilities are located less than one hour from Monmouth Medical Center.
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.